Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses

Cell

Volumn 123, Issue 3, 2005, Pages 437-448

  Wen, Yong Chen ^a,c   Wang, David H ^a   RayWhay, Chiu Yen ^a   Luo, Jianyuan ^b   Gu, Wei ^b   Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; HYPERMETHYLATED IN CANCER 1 PROTEIN; PROTEIN P53; PROTEIN SIRT1; REGULATOR PROTEIN; SIRT1 DEACETYLASE; SIRTUIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; CELL FUNCTION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DEACETYLATION; DNA DAMAGE; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; EPIGENETICS; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALIA; MAMMALIA;

EID: 27544434763     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2005.08.011     Document Type: Article

References (51)

1. V.J. Bardwell, and R. Treisman The POZ domain: a conserved protein-protein interaction motif Genes Dev. 8 1994 1664 1677
2. A. Brunet, L.B. Sweeney, J.F. Sturgill, K.F. Chua, P.L. Greer, Y. Lin, H. Tran, S.E. Ross, R. Mostoslavsky, and H.Y. Cohen Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase Science 303 2004 2011 2015
3. S. Burma, B.P. Chen, M. Murphy, A. Kurimasa, and D.J. Chen ATM phosphorylates histone H2AX in response to DNA double-strand breaks J. Biol. Chem. 276 2001 42462 42467
4. M.G. Carter, M.A. Johns, X. Zeng, L. Zhou, M.C. Zink, J.L. Mankowski, D.M. Donovan, and S.B. Baylin Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome Hum. Mol. Genet. 9 2000 413 419
5. W.Y. Chen, and T.M. Townes Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation Proc. Natl. Acad. Sci. USA 97 2000 377 382
6. W.Y. Chen, T.K. Cooper, C.A. Zahnow, M. Overholtzer, Z. Zhao, M. Ladanyi, J.E. Karp, N. Gokgoz, J.S. Wunder, and I.L. Andrulis Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis Cancer Cell 6 2004 387 398
7. W.Y. Chen, X. Zeng, M.G. Carter, C.N. Morrell, R.W. Chiu Yen, M. Esteller, D.N. Watkins, J.G. Herman, J.L. Mankowski, and S.B. Baylin Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors Nat. Genet. 33 2003 197 202
8. H.Y. Cohen, C. Miller, K.J. Bitterman, N.R. Wall, B. Hekking, B. Kessler, K.T. Howitz, M. Gorospe, R. de Cabo, and D.A. Sinclair Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase Science 305 2004 390 392
9. A.J. de Ruijter, A.H. van Gennip, H.N. Caron, S. Kemp, and A.B. van Kuilenburg Histone deacetylases (HDACs): characterization of the classical HDAC family Biochem. J. 370 2003 737 749
10. S. Deltour, C. Guerardel, and D. Leprince Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B Proc. Natl. Acad. Sci. USA 96 1999 14831 14836
11. S. Deltour, S. Pinte, C. Guerardel, B. Wasylyk, and D. Leprince The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif Mol. Cell. Biol. 22 2002 4890 4901
12. P. Dhordain, O. Albagli, R.J. Lin, S. Ansieau, S. Quief, A. Leutz, J.P. Kerckaert, R.M. Evans, and D. Leprince Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein Proc. Natl. Acad. Sci. USA 94 1997 10762 10767
13. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
14. F. Grignani, S. De Matteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F.F. Ferrara, and I. Zamir Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia Nature 391 1998 815 818
15. C. Grimm, R. Sporle, T.E. Schmid, I.D. Adler, J. Adamski, K. Schughart, and J. Graw Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome Hum. Mol. Genet. 8 1999 697 710
16. L. Guarente Sir2 links chromatin silencing, metabolism, and aging Genes Dev. 14 2000 1021 1026
17. C. Guerardel, S. Deltour, S. Pinte, D. Monte, A. Begue, A.K. Godwin, and D. Leprince Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53 J. Biol. Chem. 276 2001 3078 3089
18. S. Haldar, M. Negrini, M. Monne, S. Sabbioni, and C.M. Croce Down-regulation of bcl-2 by p53 in breast cancer cells Cancer Res. 54 1994 2095 2097
19. T.C. He, S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc. Natl. Acad. Sci. USA 95 1998 2509 2514
20. M.T. Hemann, J.S. Fridman, J.T. Zilfou, E. Hernando, P.J. Paddison, C. Cordon-Cardo, G.J. Hannon, and S.W. Lowe An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo Nat. Genet. 33 2003 396 400
21. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, R.E. Zipkin, P. Chung, A. Kisielewski, and L.L. Zhang Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
22. S. Imai, C.M. Armstrong, M. Kaeberlein, and L. Guarente Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 2000 795 800
23. J.P. Issa, Y.L. Ottaviano, P. Celano, S.R. Hamilton, N.E. Davidson, and S.B. Baylin Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat. Genet. 7 1994 536 540
24. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe Apoptosis: a link between cancer genetics and chemotherapy Cell 108 2002 153 164
25. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428
26. M. Kaeberlein, M. McVey, and L. Guarente The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms Genes Dev. 13 1999 2570 2580
27. R.J. Lin, L. Nagy, S. Inoue, W. Shao, W.H. Miller Jr., and R.M. Evans Role of the histone deacetylase complex in acute promyelocytic leukaemia Nature 391 1998 811 814
28. S.J. Lin, P.A. Defossez, and L. Guarente Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae Science 289 2000 2126 2128
29. J. Luo, A.Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, and W. Gu Negative control of p53 by Sir2alpha promotes cell survival under stress Cell 107 2001 137 148
30. J. Luo, M. Li, Y. Tang, M. Laszkowska, R.G. Roeder, and W. Gu Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo Proc. Natl. Acad. Sci. USA 101 2004 2259 2264
31. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
32. T. Miyashita, M. Harigai, M. Hanada, and J.C. Reed Identification of a p53-dependent negative response element in the bcl-2 gene Cancer Res. 54 1994 3131 3135
33. M.C. Motta, N. Divecha, M. Lemieux, C. Kamel, D. Chen, W. Gu, Y. Bultsma, M. McBurney, and L. Guarente Mammalian SIRT1 represses forkhead transcription factors Cell 116 2004 551 563
34. S. Nemoto, M.M. Fergusson, and T. Finkel Nutrient availability regulates SIRT1 through a forkhead-dependent pathway Science 306 2004 2105 2108
35. B.J. North, and E. Verdin Sirtuins: Sir2-related NAD-dependent protein deacetylases Genome Biol. 5 2004 224
36. E. Oda, R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 288 2000 1053 1058
37. T.T. Paull, E.P. Rogakou, V. Yamazaki, C.U. Kirchgessner, M. Gellert, and W.M. Bonner A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage Curr. Biol. 10 2000 886 895
38. S. Pinte, N. Stankovic-Valentin, S. Deltour, B.R. Rood, C. Guerardel, and D. Leprince The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties J. Biol. Chem. 279 2004 38313 38324
39. J. Sakamoto, T. Miura, K. Shimamoto, and Y. Horio Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain FEBS Lett. 556 2004 281 286
40. T. Senawong, V.J. Peterson, D. Avram, D.M. Shepherd, R.A. Frye, S. Minucci, and M. Leid Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression J. Biol. Chem. 278 2003 43041 43050
41. M. Serrano, H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho Role of the INK4a locus in tumor suppression and cell mortality Cell 85 1996 27 37
42. L.Q. Sun, D.W. Lee, Q. Zhang, W. Xiao, E.H. Raabe, A. Meeker, D. Miao, D.L. Huso, and R.J. Arceci Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG Genes Dev. 18 2004 1035 1046
43. H.A. Tissenbaum, and L. Guarente Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 2001 227 230
44. M. Toyota, N. Ahuja, M. Ohe-Toyota, J.G. Herman, S.B. Baylin, and J.P. Issa CpG island methylator phenotype in colorectal cancer Proc. Natl. Acad. Sci. USA 96 1999 8681 8686
45. A. Vaquero, M. Scher, D. Lee, H. Erdjument-Bromage, P. Tempst, and D. Reinberg Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin Mol. Cell 16 2004 93 105
46. H. Vaziri, S.K. Dessain, E. Ng Eaton, S.I. Imai, R.A. Frye, T.K. Pandita, L. Guarente, and R.A. Weinberg hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
47. M.M. Wales, M.A. Biel, W. el Deiry, B.D. Nelkin, J.P. Issa, W.K. Cavenee, S.J. Kuerbitz, and S.B. Baylin p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 Nat. Med. 1 1995 570 577
48. R. Weindruch, and R.L. Walford The retardation of aging and disease by dietary restriction 1988 Charles C. Thomas Springfield, IL
49. J.G. Wood, B. Rogina, S. Lavu, K. Howitz, S.L. Helfand, M. Tatar, and D. Sinclair Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689
50. W.E. Wright, M. Binder, and W. Funk Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site Mol. Cell. Biol. 11 1991 4104 4110
51. J. Yu, L. Zhang, P.M. Hwang, K.W. Kinzler, and B. Vogelstein PUMA induces the rapid apoptosis of colorectal cancer cells Mol. Cell 7 2001 673 682